Mahim Jain
Clinical Genetics (M.D.) · Wilmington, DENPI 1558660886
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,712 of the $31,159 with a category attached, or 92.1%. Travere Therapeutics, Inc. accounts for 89.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $20,522 and has fallen 98.3% since, to $357 in 2025.
Across 26 payments — averaging $1198.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$28K
- Sanofi US Services Inc.$3K
- Biomarin Pharmaceutical Inc.$192
- Ultragenyx Pharmaceutical Inc.$145
- Ascendis Pharma Endocrinology Inc$77
- Kyowa Kirin, Inc.$27
- plus $42 from 2 others
Across 47 payments — averaging $8544.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$238K
- Amgen$104K
- Ultragenyx Pharmaceutical Inc.$60K
What the payments were for
- Consulting fees$28,71292%
- Speaking & faculty fees$7382%
- Travel & lodging$1,0473%
- Food & beverage$5992%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 17 | $27,964 |
| Sanofi US Services Inc. | 1 | $2,712 |
| Biomarin Pharmaceutical Inc. | 2 | $192 |
| Ultragenyx Pharmaceutical Inc. | 2 | $145 |
| Ascendis Pharma Endocrinology Inc | 1 | $77 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$129
How this compares
Too few clinical genetics (m.d.) providers in Delawareto place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Wilmington
- Michael BoberWilmington$73K
- Nina Powell-HamiltonWilmington$5K
- Julie KaplanWilmington$393
- Karen GrippWilmington$198
- Bruce BomanNewark$59
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.